|
Q3 Events list updated
|
3
|
Resverlogix Corp.
|
Jun 26, 2015 12:23PM
|
|
Re: Statistical Significance
|
3
|
Resverlogix Corp.
|
Apr 16, 2019 10:40PM
|
|
Re: AHA Late Breaker!
|
3
|
Resverlogix Corp.
|
Sep 21, 2019 11:30AM
|
|
AGM Sept. 12, 2018
|
3
|
Zenith Epigenetics
|
Jun 29, 2018 04:45PM
|
|
Re: MACE event rate
|
3
|
Resverlogix Corp.
|
Nov 04, 2018 07:57AM
|
|
Re: Phase 3 - Fall Start
|
3
|
Resverlogix Corp.
|
Jun 22, 2015 02:14PM
|
|
Re: Bioasis Announces Filing of Its Fourth Quarter and Fiscal Year-End Financial Statements and MD&A
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 26, 2018 10:24PM
|
|
Re: PNH Trial?
|
3
|
Resverlogix Corp.
|
Jun 30, 2017 02:19PM
|
|
Re: And volume shoots up again...281K traded
|
3
|
Resverlogix Corp.
|
Dec 09, 2019 12:20PM
|
|
Re: BIO Investor Forum, Oct 22-23
|
3
|
Resverlogix Corp.
|
Oct 22, 2019 04:48PM
|
|
Re: SO078 APABETALONE, A BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, REDUCES ALKALINE PHOSPHATASE IN CVD PATIENTS....
|
3
|
Resverlogix Corp.
|
May 03, 2020 12:01PM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Mar 24, 2017 03:34PM
|
|
Re: MACE event rate
|
3
|
Resverlogix Corp.
|
Nov 04, 2018 10:22AM
|
|
Re: AHA Late Breaker!
|
3
|
Resverlogix Corp.
|
Sep 25, 2019 07:55PM
|
|
Re: 2 new upcoming presentations
|
3
|
Resverlogix Corp.
|
May 03, 2020 12:06PM
|
|
Re: time lines and yet to come...
|
3
|
Zenith Epigenetics
|
Aug 16, 2018 04:29PM
|
|
Re: Are statins overprescribed? Why the risks and benefits are so complex
|
3
|
Resverlogix Corp.
|
Dec 04, 2018 04:25PM
|
|
Re: My guesstimate for Patient Years...
|
3
|
Resverlogix Corp.
|
Jun 21, 2019 11:30AM
|
|
Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions
|
3
|
Resverlogix Corp.
|
Sep 28, 2022 04:20PM
|
|
Re: From 2018.
|
3
|
Resverlogix Corp.
|
May 03, 2020 12:09PM
|
